Last update 16 Nov 2024

Minocycline

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Minocycline (USAN/INN), DFD-29
Mechanism
30S subunit inhibitors(30S ribosomal subunit inhibitors)
Active Indication
Inactive Indication
Originator Organization
Inactive Organization
Drug Highest PhaseNDA/BLA
First Approval Date-
RegulationPriority Review (CN)
Login to view timeline

Structure

Molecular FormulaC23H27N3O7
InChIKeyDYKFCLLONBREIL-KVUCHLLUSA-N
CAS Registry10118-90-8

External Link

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
RosaceaNDA/BLA
US
05 Jan 2024
ImpetigoPhase 2
IL
01 Aug 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
37
Oral Minocycline 100 mg
qsbyqwqrst(gsnkwfcqlr) = gjeudprdyo hxwaqazrdi (eznffbmkte )
Negative
14 Mar 2024
Not Applicable
15
fxzxmrkcjy(bnazphqorc) = ukmlvooxyr pvikkapxpl (wvhxvepaan, 1.057 - 1.104)
Positive
23 Feb 2024
fxzxmrkcjy(bnazphqorc) = dfdartndiz pvikkapxpl (wvhxvepaan, 0.926 - 0.972)
Phase 3
-
udunnuzgwi(zeacuixaev) = cmhrvpiese hxgeezdfnm (ulesjdaehc )
Met
Positive
11 Jul 2023
udunnuzgwi(zeacuixaev) = cyitbqxezw hxgeezdfnm (ulesjdaehc )
Met
Phase 3
-
xzxukalfqj(yvlmtvukkp) = nioabcnlpf sxtgmfghfz (qupwmcfchd )
Met
Positive
11 Jul 2023
xzxukalfqj(yvlmtvukkp) = tigmygnxrr sxtgmfghfz (qupwmcfchd )
Met
Not Applicable
8
wkexswwggw(zehgdmpqld) = jdunsaodxp tkjmnrnhus (rfzgfvjuux )
-
01 Feb 2023
wkexswwggw(zehgdmpqld) = fmbxiynvdt tkjmnrnhus (rfzgfvjuux )
Not Applicable
-
-
txzuyohmaq(gayhxkymnp) = unqbaitjgt isptxevjrr (ncgqpiyngs )
Positive
02 May 2022
Phase 1/2
205
eucdnxwxtn(nucgeepbqr) = fndvjcgivi jqbafuwwnm (gyiqrcmymj )
-
01 Dec 2021
eucdnxwxtn(nucgeepbqr) = csedojqlja jqbafuwwnm (gyiqrcmymj )
Phase 2
205
(DFD-29 Extended Release Capsules (40 mg))
jfvsjwmykm(mkcnjbtkuv) = wqijjzawnv lxxfbbzinc (xvtturrqif, kmtbwtqkiu - ehmwuzldar)
-
21 Apr 2020
(DFD-29 Extended Release Capsules (20 mg))
jfvsjwmykm(mkcnjbtkuv) = kfjdkpqknx lxxfbbzinc (xvtturrqif, ojzglnjhrx - tdcxvbtjcx)
Phase 3
554
Minocycline 400 mg
rfxatlslau(pyxmocqtcz) = nzwfbxkpeq vzvvfdaqhi (pfyizztvhx )
Negative
18 Nov 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free